Search results
US FDA staff flags concerns on MDMA-assisted PTSD treatment
WHTC 1450 Holland· 4 days ago(Reuters) -The U.S. health regulator's staff reviewers on Friday raised concerns related to...
What is MDMA? | National Institute on Drug Abuse
Mountain View Telegraph· 2 days agoMDMA is a synthetic drug that acts as a stimulant and hallucinogen.15–17 It produces an energizing effect, distortions in time and perception, and enhanced enjoyment from ...
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD - ABC17NEWS
ABC17 NEWS· 4 days agoFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. The Food and Drug Administration posted ...
The FDA is weighing whether to approve MDMA for PTSD. Here's what that could look like for patients.
CBS News· 4 days agoAhead of a key meeting Tuesday to weigh the potential approval of midomafetamine, or MDMA, for...
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
Dayton Daily News· 4 days agoWASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first...
US FDA staff raises concerns over data from MDMA-based PTSD therapy
Colorado Springs Gazette· 4 days agoFood and Drug Administration's advisory panel on Tuesday, as the agency reviews the therapeutic use...
Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules
Digital Journal· 6 days ago(CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as psilocybin and MDMA ...
US FDA staff raises concerns over data from MDMA-based PTSD therapy By Reuters
Investing.com· 4 days agoFood and Drug Administration's advisory panel on Tuesday, as the agency reviews the therapeutic use...
Psychedelics Have a Placebo Problem
The Atlantic· 16 hours agoTomorrow, a Food and Drug Administration advisory committee will meet to discuss whether the United States should approve its first psychedelic drug. The...
FDA’s review of MDMA for PTSD highlights study bias and safety concerns
Ars Technica· 3 days agoI believe the symptoms mentioned in those sentences are generally symptoms of the "it gets worse before it gets better" phase of therapy for those with severe trauma. Psychedelics, when used ...